3. As of noon trading, DaVita HealthCare Partners ( DVA) is up $0.76 (0.62) to $123.88 on average volume Thus far, 331,845 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 787,800 shares. The stock has ranged in price between $122.57-$124.93 after having opened the day at $123.20 as compared to the previous trading day's close of $123.12.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $13.2 billion and is part of the health care sector. The company has a P/E ratio of 30.0, above the S&P 500 P/E ratio of 17.7. Shares are up 11.4% year to date as of the close of trading on Wednesday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DaVita HealthCare Partners Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

Health Care and Pharma Feeling the Wrath of Trump: Cramer's 'Mad Money' Recap (Wednesday 1/11/17)

Berkshire Hathaway, SAP, Dominion Resources: 'Mad Money' Lightning Round

These 5 Health Care Stocks Are Breaking Out This Christmas

Analysts' Actions -- AK Steel, Mettler-Toledo, Pure Storage, Phillips 66 and More